Dillon v. Medtronic, Inc.

992 F. Supp. 2d 751, 2014 WL 37759, 2014 U.S. Dist. LEXIS 747
CourtDistrict Court, E.D. Kentucky
DecidedJanuary 6, 2014
DocketCivil No. 13-105-ART
StatusPublished
Cited by31 cases

This text of 992 F. Supp. 2d 751 (Dillon v. Medtronic, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dillon v. Medtronic, Inc., 992 F. Supp. 2d 751, 2014 WL 37759, 2014 U.S. Dist. LEXIS 747 (E.D. Ky. 2014).

Opinion

AMENDED AND SUPERSEDING MEMORANDUM OPINION AND ORDER

AMUL R. THAPAR, District Judge.

Congress offers two roads into federal court based on federal questions, and the state-court defendants in this case seek to take the one less traveled. Unfortunately that road is closed to them. Although the defendants allege federal law preempts the plaintiffs’ claims, preemption is merely a defense, and thus does not count for the purposes of jurisdiction. The Court must therefore remand this case back to state court, since no federal issue appears on the face of the plaintiffs’ well-pleaded complaint.

BACKGROUND

Plaintiffs Winston and Teresa Dillon brought this suit against Medtronic, Inc. and its codefendants (collectively, “Medtronic”) in Pike County Circuit Court. See R. 1-1. The Dillons assert various state causes of action including negligence, products liability, and several fraud-related claims. Id. They seek damages for injuries allegedly caused during Mr. Dillon’s spine fusion surgery. According to the Dillons, the doctor used Medtronic’s Infuse Bone Graft device in a manner that the Food and Drug Administration (FDA) did not approve for inclusion on the device’s label. Id. ¶¶ 321-27. And, the Dillons claim Medtronic is responsible for their injuries because it illegally promoted such “off-label” use of Infuse. Id. ¶ 200. Medtronic counters that federal law preempts the Dillons’ claims. See R. 14 (motion to dismiss). The defendants accordingly removed the case to this Court, invoking its federal-question jurisdiction to hear cases “arising under” federal law. See R. 1 ¶ 13 (citing 28 U.S.C. § 1331). The plaintiffs moved to remand. See R. 11.

Federal law regulates medical devices pursuant to the Medical Device Amendments (MDA) to the Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. §§ 360c et seq. See Riegel v. Medtronic, Inc., 552 U.S. 312, 316-20, 128 S.Ct. 999, 169 L.Ed.2d 892 (2008) (describing the rigorous regulatory regime). The MDA provides varying degrees of oversight for medical devices depending on the risks they carry. Id. at 316, 128 S.Ct. 999. Class III devices like Infuse are the most heavily regulated. Id. at 317, 128 S.Ct. 999; R. 1-1 ¶ 136 (discussing Infuse). In line with the comprehensive federal regime, Congress expressly preempted all state requirements — including common law duties, see Riegel, 552 U.S. at 325, 128 S.Ct. 999 — relating to medical devices that are “different from, or in addition to,” federal standards. 21 U.S.C. § 360k(a)(l). The MDA preemption clause does not, however, bar so-called “parallel” claims for breaches of common-law duties that also violate federal law. Riegel, 552 U.S. at 330, 128 S.Ct. 999; Medtronic, Inc. v. Lohr, 518 U.S. 470, 495, 116 S.Ct. 2240, 135 L.Ed.2d 700 (1996). Despite occupy[754]*754ing much of the medical device field, Congress explicitly chose not to provide a private cause of action to consumers harmed by violations of the FDCA, favoring exclusive government enforcement instead. See Buckman Co. v. Plaintiffs’ Legal Comm., 531 U.S. 341, 349 n. 4, 121 S.Ct. 1012, 148 L.Ed.2d 854 (2001) (citing 21 U.S.C. § 337(a)). As a result, federal law impliedly preempts state claims based solely on violations of the FDCA. Id. at 352-53, 121 S.Ct. 1012; see also Fulgenzi v. PLIVA, Inc., 711 F.3d 578, 586 (6th Cir.2013) (holding that claims owing their existence to the FDCA regulatory scheme are preempted). Medtronic contends that together, § 360k(a) and § 337(a) preempt the Dillons’ state law claims based on off-label promotion, and preemption therefore injects the federal question necessary for this case to fall within the Court’s subject matter jurisdiction. See R. 26 at 9-10.

DISCUSSION

The defendants may remove this case to federal court if the Dillons could have originally brought it here. See 28 U.S.C. § 1441(a). Unlike state trial courts, however, federal district courts do not possess general jurisdiction. As courts of more limited jurisdiction, federal courts instead hold only that power authorized by the Constitution and conferred by statute. See Gunn v. Minton, — U.S. -, 133 S.Ct. 1059, 1064, 185 L.Ed.2d 72 (2013). As the party seeking removal, Medtronic has the burden of demonstrating that the Court has such jurisdiction. Eastman v. Marine Mech. Corp., 438 F.3d 544, 549 (6th Cir.2006). Kentucky courts are presumptively competent to interpret and faithfully apply federal law. See Mikulski v. Centerior Energy Corp., 501 F.3d 555, 560 (6th Cir.2007) (en banc).

I. The Law of Federal Question Jurisdiction

The Constitution permits federal courts to hear “Cases ... arising under” the Constitution and federal law. U.S. Const. art. III, § 2. Early precedent interpreting Article III suggests this phrase may encompass all cases in which a federal question is anywhere an “ingredient.” Osborn v. Bank of the United States, 22 U.S. (9 Wheat.) 738, 823-25, 6 L.Ed. 204 (1824). But see Anthony J. Bellia Jr., Article III and the Cause of Action, 89 Iowa L.Rev. 777, 801-03, 808 (2004) (arguing that this language in Osborn referred to an essential component of the cause of action). Nevertheless, the Constitution describes only cases that Congress may permit federal district courts to hear. District courts have no jurisdiction without congressional authorization since Article III is not self-executing. See Hertz Corp. v. Friend, 559 U.S. 77, 84, 130 S.Ct. 1181, 175 L.Ed.2d 1029 (2010). And Congress generally speaking has the discretion to confer only a subset of what jurisdiction the Constitution allows. Id. Largely tracking the language of Article III, Congress has conferred on district courts jurisdiction over “all civil actions arising under the Constitution, laws, or treaties of the United States.” 28 U.S.C. § 1331. Despite the similar phrasing to the Constitution, the Supreme Court has concluded § 1331 encompasses fewer cases than constitutionally permitted. See Merrell Dow Pharm. Inc. v. Thompson, 478 U.S. 804, 807-08, 106 S.Ct. 3229, 92 L.Ed.2d 650 (1986).

A. The “Well-Pleaded Complaint” Rule

Most importantly, for statutory purposes a case only “arises under” federal law if a federal issue appears amid the plaintiffs cause of action. See Louisville & Nashville R.R. Co. v. Mottley, 211 U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
992 F. Supp. 2d 751, 2014 WL 37759, 2014 U.S. Dist. LEXIS 747, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dillon-v-medtronic-inc-kyed-2014.